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To the Editor:
The authors read with interest the article about the perfor-
mance of three risk stratifying scores in patients with upper 
gastrointestinal bleeding (UGIB) applied in a Korean population, 
by Choe et al.,1 recently published in Gut and Liver.
UGIB is one of the most common emergencies for gastro-
enterologists, and, as previously discussed in the mentioned 
article, early risk stratification is important to determine priori-
ties and define which patients benefit from early endoscopy and 
more aggressive clinical intervention. Although there are risk 
scores to predict clinical outcomes in UGIB, the most used be-
ing the Glasgow-Blatchford score (GBS), Rockall score (RS), and 
AIMS65 score (AIMS65), uncertainty still exists about the op-
timal score that could be uniformly applied in clinical practice. 
In addition, because most studies about risk scoring excluded 
patients with variceal bleeding, few data are available on the 
use of this scores in patients with variceal bleeding.
We recently conducted a retrospective single-center study 
which compared the performance of three scoring systems (GBS, 
RS, and AIMS65) in Portuguese patients. The consecutive pa-
tients admitted to our institution’s emergency department with 
UGIB over a period of 12 months (between January 2016 and 
December 2016) were included. Both patients with variceal and 
nonvariceal bleeding were included. Two major endpoints were 
considered: (1) composite endpoint–need for any clinical inter-
vention (transfusion, endoscopic therapy, surgery or radiologi-
cal intervention) and (2) UGIB related mortality at 30 days after 
admission. The accuracy of each scoring system for the consid-
ered endpoints was calculated using the area under the receiver 
operating characteristic curve (AUROC), with 95% confidence 
interval. Statistical analysis was performed on MedCalc® statis-
tical software (Medcalc Software, Mariakerke, Belgium).
A total of 202 patients were included, the majority (75%) 
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Table 1. Characteristics and Clinical Outcomes of the Study Popula-
tion (n=202)
Variable Value
Age, yr 67 (31–94)
Male sex 151 (75)
Comorbidities
    Heart failure 38 (19)
    Chronic liver disease 55 (27)
    Chronic kidney disease 20 (10)
    Metastatic malignancy 24 (12)
Endoscopic findings
    None 12 (6)
    Erosive disease*  32 (16)
    Gastric or duodenal ulcer  75 (37)
    Variceal bleeding  49 (24)
    Malignancy of the upper GI tract 14 (7)
    Dieulafoy 6 (3)
    Mallory-Weiss tear 6 (3)
    Gastric/duodenal angiodysplasia 8 (4)
Mean time of hospital stay, day  8.9 (0–32)
Treatments
    Blood transfusion  93 (46)
    Endoscopic treatment 101 (50)
    Surgery 12 (6)
Outcome
    30-Day mortality 14 (7)
Mean score
    Glasgow-Blatchford 10.1 (0–20)
    AIMS65 1.5 (0–4)
    Rockall  5.8 (0–11)
Data are presented as mean (range) or number (%).
GI, gastrointestinal.
*Esophagitis, gastritis, and duodenitis.
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being male, with a mean age of 67 years. The mean time from 
admission to endoscopy was 15.8 hours. The main endoscopic 
findings were peptic ulcer disease (37%), variceal bleeding (24%) 
and erosive disease (16%). Six percent of patients had normal 
endoscopy. The overall rate of 30-day mortality directly related 
to the UGIB was 7%. The characteristics and the outcomes of 
the series of patients are described in Table 1. For the composite 
endpoint (need for clinical intervention), the AUROCs of GBS, 
RS, and AIMS65 were, respectively, 0.833, 0.781 and 0.636 in 
nonvariceal bleeding versus 0.630, 0.543 and 0.620 in variceal 
bleeding (Figs 1 and 2). For 30-day mortality, the AUROCs of 
RS, AIMS65 and GBS were, respectively, 0.864, 0.822 and 0.807 
in nonvariceal bleeding and 0.783, 0.826 and 0.793 in variceal 
bleeding (Figs 3 and 4). 
GBS was the only effective score to predict the need for clini-
cal intervention, but in our population that was only true for 
patients with nonvariceal bleeding. Regarding mortality, the 
three scores showed a reasonable performance for both variceal 
and nonvariceal bleeding, but AIMS65 outperformed GBS. 
As in the Korean study, GBS seems superior in its ability to 
predict need for clinical intervention in the nonvariceal bleeding 
group. Although we had a similar percentage of patients with 
variceal bleeding as the Korean study, we could not conclude 
the same in that specific group of patients. GBS seems the best 
score to predict need for clinical intervention in patients with 
nonvariceal bleeding, but we would not recommend its use in 
the variceal group in the Portuguese population. 
As in the Korean population, AIMS65 does not seem good to 
predict clinical intervention in patients admitted with UGIB in 
the Portuguese population. However, it outperformed GBS and 
seems a good score to predict mortality both in the nonvariceal 
and variceal bleeding patients. In fact, AIMS65 was designed to 
Fig. 1. Area under the receiver operating characteristic curve (AUROC) 
of Glasgow-Blatchford score (GBS), Rockall score (RS), and AIMS65 
score (AIMS65) in predicting need for clinical intervention in non-
variceal upper gastrointestinal bleeding.
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Fig. 2. Area under the receiver operating characteristic curve (AUROC) 
of Glasgow-Blatchford score (GBS), Rockall score (RS), and AIMS65 
score (AIMS65) in predicting need for clinical intervention in variceal 
upper gastrointestinal bleeding.
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Fig. 3. Area under the receiver operating characteristic curve (AUROC) 
of Glasgow-Blatchford score (GBS), Rockall score (RS), and AIMS65 
score (AIMS65) in predicting 30-day mortality in nonvariceal upper 
gastrointestinal bleeding.
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Fig. 4. Area under the receiver operating characteristic curve (AUROC) 
of Glasgow-Blatchford score (GBS), Rockall score (RS), and AIMS65 
score (AIMS65) in predicting 30-day mortality in variceal upper gas-
trointestinal bleeding.
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determine predictors of mortality.2 We should keep in mind that 
each score was developed to determine a specific, and some-
times different, outcome. Regarding RS, contrary to GBS and 
AIMS65, it requires endoscopic features, so it is not useful to 
stratify patients at admission.3
In conclusion, in the Portuguese population, GBS seems the 
best score that predicts need for clinical intervention, but only 
in patients with nonvariceal UGIB. Although the AIMS65 score 
is not optimal at predicting clinical intervention, it seems a good 
at predicting mortality, both in the nonvariceal and variceal 
UGIB Portuguese population. Although these scores systems are 
helpful to stratify UGIB patients, its application to different pop-
ulations should be used with caution, since the causes of UGIB 
differ considerably among countries.1 An ideal scoring system 
that is uniformly and universally appropriate in clinical practice 
is yet to be defined. 
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